9 news items
Catheter Precision, Inc. (NYSE American: VTAK) Reports Q1 2024 Highlights and Operational Performance Report
VTAK
6 May 24
operations are subject to pervasive and continuing FDA regulatory requirements, our products may be subject to additional recalls, revocations
Catheter Precision, Inc. (NYSE-American: VTAK) Announces New Chief Commercial Officer
VTAK
1 May 24
and continuing FDA regulatory requirements, our products may be subject to additional recalls, revocations or suspensions after receiving FDA or foreign approval
Catheter Precision, Inc. (VTAK) Announces Receipt of First Purchase Order for LockeT from HCA Healthcare Facility
VTAK
24 Apr 24
be subject to additional recalls, revocations or suspensions after receiving FDA or foreign approval or clearance, which could divert managerial
Catheter Precision, Inc. (NYSE-American:VTAK) Expands Sales Team; Expects Corresponding Rise in Revenue Over the Near Term; Anticipates Breakeven by End of Year
VTAK
4 Apr 24
products may be subject to additional recalls, revocations or suspensions after receiving FDA or foreign approval or clearance, which could divert
Catheter Precision, Inc. (NYSE American:VTAK) to Sponsor the Monaco USA Arrhythmia Course
VTAK
19 Mar 24
to pervasive and continuing FDA regulatory requirements, our products may be subject to additional recalls, revocations or suspensions after receiving FDA
wxpdlvct1 kd1asn2n7t6mv9p8fvtce04zvkgdtilc9w4f
VTAK
11 Mar 24
requirements, our products may be subject to additional recalls, revocations or suspensions after receiving FDA or foreign approval or clearance, which
p421 l373
VTAK
28 Feb 24
and continuing FDA regulatory requirements, our products may be subject to additional recalls, revocations or suspensions after receiving FDA or foreign
3gyjiaxa9n
VTAK
26 Feb 24
to additional recalls, revocations or suspensions after receiving FDA or foreign approval or clearance, which could divert managerial and financial
jg3slof0935 i0kboo3l9h
VTAK
22 Feb 24
medical device operations are subject to pervasive and continuing FDA regulatory requirements, our products may be subject to additional recalls
- Prev
- 1
- Next